biotech
Bio-AnalystSupplement research
person

Citrulline

Blood pressure and vascular health

Human studies reported between-group improvement in Brachial artery flow-mediated dilation.

Single-ingredient studies · Human studies · Population not specified · between-group comparison

Publications for this result: 1

Other outcomes and study details

Distinct publications linked to this topic: 16

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.

What has been studied?

Distinct human comparison papers: 2

Some studies tested several ingredients together. Those results cannot show this ingredient’s separate effect or establish synergy.

  • Brachial artery flow-mediated dilation

    • Comparison result:A better result than the comparison group was reported.
      Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • diastolic blood pressure

    • Comparison result:A better result than the comparison group was reported.
      Patient group · Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • resting BP

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      General population · Combination study
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Ingredient combination
      • General population
      • Outcome role not specified
      • Within-group comparison
      • Timepoint: acute post-supplement and submaximal leg-extension protocol
      • Study comparison: within-subject crossover among citrulline malate, beetroot nitrate, and placebo
  • SBP

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      General population · Unspecified.
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Unknown intervention
      • General population
      • Outcome role not specified
      • Timepoint: Unspecified.
      • Study comparison: Pooled review/meta-analysis result as reported; abstract result sentence does not identify the compa

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (6)
  • atherogenic-endothelial protection · Distinct papers needing additional review: 1Evidence criteria check: 1
  • blood pressure · Distinct papers needing additional review: 1Evidence criteria check: 1
  • blood pressure regulation · Distinct papers needing additional review: 1Evidence criteria check: 1
  • endothelial senescence · Distinct papers needing additional review: 1Evidence criteria check: 1
  • FMD · Distinct papers needing additional review: 1Evidence criteria check: 1
  • sfemFMD · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Exercise performance

    Related papers 21 · human comparison papers 5

    View results
    • completion time · Improvement reported
    • Physical performance · Improvement reported · Some studies used more than one ingredient

    More outcome groups: 16

  • Blood pressure and vascular health

    Related papers 16 · human comparison papers 2

    View selected result
  • Glucose and metabolic health

    Related papers 3 · comparison findings need further review

    View results
    • circulating glucose · Interpretation held
  • Fatigue and energy

    Related papers 1 · comparison findings need further review

    View results
    • rate of fatigue · Interpretation held
  • Stress and mood

    Related papers 1 · comparison findings need further review

    View results
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 61.4 evidence score includes 15 independent human studies and 15 clinical studies in the representative benefit area. The B tier remains conservative because of a meaningful share of null findings in the same benefit area.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 76

Papers linked to this topic 16 · distinct papers 16 · papers with a confirmed human comparison 2 · papers needing additional review 12

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • atherogenic-endothelial protection: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • blood pressure: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • blood pressure regulation: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Brachial artery flow-mediated dilation: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • diastolic blood pressure: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • endothelial senescence: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • FMD: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • resting BP: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • SBP: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sfemFMD: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Exercise performance

What the research found

swimming performance

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

completion time

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

number of repetitions

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Physical performance

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Sprint performance decrement

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

total upper body (the sum of BP and IP) RTF

The study reported improvement in this measurement.

Controlled study in people · Separable contribution · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

exercise performance

A change was reported, but the comparison could not be confirmed.

Review · Unknown intervention · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

ergogenic effect

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

lean mass

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

muscle mass

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

muscle strength

The study needs further checking before its result can be interpreted.

Controlled study in people · Separable contribution · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

peak power

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

performance

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

strength-endurance

The study needs further checking before its result can be interpreted.

Controlled study in people · Separable contribution · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

time to fatigue

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

time to reach peak power

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TT time

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TTE

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood pressure and vascular health

What the research found

resting BP

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Brachial artery flow-mediated dilation

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

diastolic blood pressure

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SBP

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

atherogenic-endothelial protection

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

blood pressure

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

blood pressure regulation

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

endothelial senescence

The study needs further checking before its result can be interpreted.

Cell study · indirect · Ingredient combination · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

endothelial senescence

The study needs further checking before its result can be interpreted.

Cell study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

FMD

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sfemFMD

The study needs further checking before its result can be interpreted.

Controlled study in people · Separable contribution · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

4 papers · 4 measured outcomes

4 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Glucose and metabolic health

What the research found

circulating glucose

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fatigue and energy

What the research found

rate of fatigue

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
1
Findings from individual and combined use, plus reviewed cautions
Key precautions
No reviewed caution rules are available yet. Reported caution findings are shown below.
These findings were reported in studies. They do not predict an individual's experience.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

number of repetitions1 papers
In a crossover RCT of 41 men, 8 g of citrulline malate increased repetitions to fatigue by 52.92 % and reduced muscle soreness by 40 % compared with placebo, with mild stomach discomfort reported in 14.63 % of participants.Human studies · Randomized controlled trial